Dr Joachim Hombach is Senior Adviser in the Department of Immunisation, Vaccines and Biologicals. In his former managerial positions at WHO, he was interim Head of the Initiative for Vaccine Research, and Coordinator in charge of policy & strategy and implementation research. He also served as focal point for the flavivirus vaccine portfolio, with particular emphasis on dengue and Japanese encephalitis vaccines.
Before joining WHO, Joachim Hombach’s career focused on vaccine research and implementation policy, with emphasis on vaccines for the developing world. In this context, he had assignments as Director of vaccine policy at GlaxoSmithKline Biologicals S.A., and as Scientific Officer with the European Commission. In the latter function, he was seminal in setting up the European and Developing Countries Clinical Trials Partnership.
Joachim Hombach’s career started as a researcher in molecular and cellular immunology at the University of Zürich, Switzerland and the Max-Planck Institute for Immunology in Freiburg, Germany. He holds a PhD from the University of Cologne, Germany, as well as a Master of Public Health from Johns Hopkins University, Baltimore, USA. Multiple peer-reviewed publications have emerged from his work.
Joachim Hombach’s areas of expertise can be summarised as follows: Immunology, vaccine development and evaluation; vaccination and public health.